{"doi":"10.17615/0ws3-zc65","title":"D-2-hydroxyglutarate is essential for maintaining oncogenic property of mutant IDH-containing cancer cells but dispensable for cell growth","abstract":"Cancer-associated isocitrate dehydrogenase (IDH) 1 and 2 mutations gain a new activity of reducing α-KG to produce D-2-hydroxyglutarate (D-2-HG), which is proposed to function as an oncometabolite by inhibiting α-KG dependent dioxygenases. We investigated the function of D-2-HG in tumorigenesis using IDH1 and IDH2 mutant cancer cell lines. Inhibition of D-2-HG production either by specific deletion of the mutant IDH1-R132C allele or overexpression of D-2-hydroxyglutarate dehydrogenase (D2HGDH) increases α-KG and related metabolites, restores the activity of some α-KG-dependent dioxygenases, and selectively alters gene expression. Ablation of D-2-HG production has no significant effect on cell proliferation and migration, but strongly inhibits anchorage independent growth in vitro and tumor growth in xenografted mouse models. Our study identifies a new activity of oncometabolite D-2-HG in promoting tumorigenesis.","journal":"UNC Libraries","year":2020,"id":116063,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":2,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9589,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2020-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":542917,"name":"Yukun Xia","orcid":"0000-0002-8728-9745","position":1,"is_corresponding":false},{"id":538240,"name":"Wanglong Deng","orcid":null,"position":2,"is_corresponding":false},{"id":543741,"name":"Zhong Kai Gu","orcid":null,"position":3,"is_corresponding":false},{"id":429413,"name":"Shenghong Ma","orcid":null,"position":4,"is_corresponding":false},{"id":543742,"name":"Fei Zhen Wu","orcid":null,"position":5,"is_corresponding":false},{"id":487268,"name":"Hui Yang","orcid":"0000-0003-0304-5098","position":6,"is_corresponding":false},{"id":63630,"name":"Yue Xiong","orcid":"0000-0003-2744-6566","position":7,"is_corresponding":false},{"id":255072,"name":"Dan Ye","orcid":"0000-0003-4848-0501","position":8,"is_corresponding":false},{"id":542918,"name":"Bowen Jiang","orcid":"0000-0003-4048-0814","position":9,"is_corresponding":false},{"id":232660,"name":"Kun‐Liang Guan","orcid":"0000-0003-1892-0174","position":10,"is_corresponding":false},{"id":522180,"name":"Tingting Li","orcid":"0000-0001-5511-7626","position":0,"is_corresponding":true}],"reference_count":0,"raw_metadata":null,"created_at":"2026-07-18T23:13:40.596604Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}